openPR Logo
Press release

Global Over the Counter (OTC) Drugs Market Growth, Size, Report & Forecast to 2020-2026

06-28-2020 08:27 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

The global OTC drug market is anticipated to grow at a CAGR of around 7% during the forecast period. Over the counter or OTC drugs can be bought without a prescription from any pharmacy or even some grocery store and supermarkets. One of the most popular categories of OTC drugs is pain management OTC drugs that are intended to reduce fever and temporarily relieve minor aches and pains. These OTC pain drugs are easily available and are commonly used in day to day life for curing small pain or fever. The frequent use of OTC pain drugs is driving the OTC drug industry.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/over-the-counter-otc-drugs-market

Acetaminophen is the most common active drug ingredient across the globe and is found in more than 600 OTC and prescription medications including pain relievers, fever reducers, sleep aids, and many coughs cold and allergy medications. Many medicines contain acetaminophen as an active ingredient, for instance, prescription (Rx) and OTC medicines such as Tylenol. The wide availability of acetaminophen as OTC is anticipated to accelerate the OTC drug market growth during the forecast period.

A Full Report of Global Over the Counter (OTC) Drugs Market is Available at: https://www.omrglobal.com/industry-reports/over-the-counter-otc-drugs-market

Similarly, NSAID is another category of OTC pain drug that is commonly used across the globe. NSAIDs can be found in more than 900 OTC and prescription medications. The most well-known NSAID OTC are aspirin ibuprofen and naproxen sodium. Several OTC pain medications available in the market also combine both acetaminophen and NSAID. Having so many options to choose from OTC drugs is anticipated to accelerate the OTC drug market during the forecast period.

Though OTC drugs are generally safe, however, they have several side effects if not taken properly. Additionally, taking more than directed dosage of OTC drugs can lead to several life-threatening conditions such as liver damage, brain damage, stroke, and others. Along with this, OTC drugs are also not advised to the person above 60, pregnant, or breastfeeding women without consulting physicians. This presents a challenge to the growth of the OTC market during the forecast period.

Global Over the counter (OTC) Drugs market- Segmentation

By Product Type

Analgesics & Pain Relievers
Cough, Cold & Flu Products
Vitamin & Mineral Supplements
Ophthalmic Products
Others

By Distribution Channel

Retail & Supermarkets
Online Platform

Global Over the Counter (OTC) Drugs Market- Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East Africa

Company Profiles

Achelios therapeutics., Inc.
Alkem Laboratories Ltd.
Amgen Inc.
Amway Corp.
AstraZeneca PLC
Bayer AG
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co.
Cipla Ltd.
Dr. Reddy’s Laboratories Ltd.
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd
Johnson & Johnson Services, Inc.
Merck KGaA
Novartis International AG

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/over-the-counter-otc-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Over the Counter (OTC) Drugs Market Growth, Size, Report & Forecast to 2020-2026 here

News-ID: 2081181 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to